New York, USA – June 18, 2021 – CD Genomics is one of the leading service providers in the area of genomic sequencing and data analysis. The company offers qualified bacterial whole-genome sequencing services to support the research concerning microbial identification, novel gene discovery, gene functional analysis, and more.
Even though 16S rRNA gene sequencing has been effectively employed for bacterial detection, two bacterial species often have sequences of 16S rRNA genes that are nearly identical and are therefore indistinguishable by this method. The correlation of genomes can be utilized in such situations to see whether the genomes emerge from the same species. The accessibility of an ever-increasing amount of genomic sequences per species gives the chance, on the basis of whole-genome data, of improving distance determinations. To define the strain at the species level, the genome of the query microbes can be evaluated with all established bacterial genomes, giving important perspectives for species identification. For accurate microbial detection, sequencing schemes such as de novo sequencing and re-sequencing of whole-genome are essential.
“We found that isolates of P. aeruginosa harboring the 28.9-kb plasmid pNECK1 and belonging to international ‘high-risk’ clone were responsible for an outbreak in one hospital,” said one researcher who works on a joint project between CNR Résistance aux antibiotiques and Laboratoire Chrono-environnement, France. “We chose PacBio SMRT sequencing offered by CD Genomics for longer contigs generation regarding bacterial whole-genome de novo sequencing,” he continues, “the project went smoothly and we got satisfying results. These data provided an insight into the complex and unpredictable routes of diffusion of some resistance determinants.”
“CD Genomics’s bacterial whole-genome sequencing platform leverages the power of high-throughput sequencing technology to generate accurate draft or complete genomes for microbial identification and comparative genomic studies. Next-generation sequencing and SMRT sequencing are our strong suits. We provide reliable sequencing approaches and confidential bioinformatics analysis to help you gain an insight into functional elements, functional genes, and phylogeny,” said Chief Scientist of CD Genomics.
“Within a community for which a reference genome is accessible, comparative genomic research can recognize specific gene variants and large-scale structural alterations. While de novo sequencing can be used for the deduction of evolutionary features and phylogenetic interactions,” Chief Scientist added, “the probability of gene finding and annotation is provided by microbial whole-genome sequencing. Novel biochemical processes that may be advantageous for medicine and biotechnology will probably be defined after multiple genes are stated.”
CD Genomics provides next-generation sequencing and long-read sequencing technologies to sequence bacterial whole genome, utilizing the advanced Illumina HiSeq, Nanopore MinION, and PacBio SMRT platforms to produce high-quality sequencing data quickly and efficiently.
About CD Genomics
CD Genomics is one of the top genomic research service providers, providing reliable services to pharmaceutical and biotech companies as well as academia and government agencies. At CD Genomics, experienced specialists will work closely with researchers to determine the optimal sequencing strategy based on the specific research focus. With state-of-the-art sequencing platforms and years of industry experience, CD Genomics guarantees high-quality data and integrated bioinformatics analyses.